Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Saccharomyces Boulardii on Antibiotic-perturbed Microbiota in Children
NCT07015736Phase 4Completed
- Sponsor
- Eskişehir Osmangazi University
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of saccharomyces boulardii in antibiotic-associated diarrhea (AAD), sponsored by Eskişehir Osmangazi University. Started Aug 2025; status: completed.
02
Drugs
saccharomyces boulardii
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT07015736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07015736.